High Expression of SMYD3 Indicates Poor Survival Outcome and Promotes Tumour Progression Through an IGF-1R/AKT/E2F-1 Positive Feedback Loop in Bladder Cancer.
Guoliang Wang,Yi Huang,Feilong Yang,Xiaojun Tian,Kun Wang,Li Liu,Yidong Fan,Xiaofeng Li,Luchao Li,Benkang Shi,Yichang Hao,Chuanyou Xia,Qingsheng Nie,Yue Xin,Zhenfeng Shi,Lulin Ma,Dawei Xu,Cheng Liu
DOI: https://doi.org/10.18632/aging.102718
2020-01-01
Aging
Abstract:The AKT/mTOR pathway is critical for bladder cancer (BC) pathogenesis and is hyper-activated during BC progression. In the present study, we identified a novel positive feedback loop involving oncogenic factors histone methyltransferase SMYD3, insulin-like growth factor-1 receptor (IGF-1R), AKT, and E2F-1. SMYD3 expression was significantly up-regulated in BC tumors and positively associated with histological grade, lymph node metastasis, and shorter patient survival. Depletion of SMYD3 inhibited BC cell proliferation, colony formation, migration, invasion, and xenograft tumor growth. Mechanistically, SMYD3 inhibition led to the diminished AKT/mTOR signaling activity, thereby triggering deleterious effects on BC cells. Furthermore, SMYD3 directly activates the expression of IGF-1R, a critical activator of AKT in BC, by inducing hyper-methylation of histone H3-K4 and subsequent chromatin remodeling in the IGF-1R promoter region. On the other hand, E2F-1, a downstream factor of the AKT pathway, binds to the E2F-1 binding motifs at the SMYD3 promoter and consequently induces SMYD3 transcription and expression. Thus, SMYD3/IGF-1R/AKT/E2F-1 forms a positive feedback loop leading to the hyper-activated AKT signaling. Our findings provide not only profound insights into SMYD3-mediated oncogenic activity but also present a unique avenue for treating BC by directly disrupting this signaling circuit.